Chicago Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Chicago Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,500	Closed	-$1.09M	–	40
2023 Q4	$1.09M	Buy	+17,500	New	+$435K	1.73%	20

Chicago Capital Management's RYZB Position: Q1 2024 in Review

Chicago Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 17,500 shares — an estimated $1.09M sold.

Chicago Capital Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $1.09M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Chicago Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Chicago Capital Management sold 17,500 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $1.09M.
Chicago Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Chicago Capital Management's RayzeBio, Inc. Common Stock position peaked at $1.09M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Chicago Capital Management's 13F filing for Q1 2024, filed 9 May 2024.